Welcome!
Raffles Medical Group (RMG)
Results
Raffles Medical Group's 3Q18 earnings come in flat at $16.4 mil
SINGAPORE (Oct 29): Raffles Medical Group (RMG) posted $16.4 million in earnings for the 3Q ended Sept, unchanged from a year ago on higher expenses.
October 29, 2018
Broker's Calls
Raffles Medical's China Taiping partnership to benefit in China, Singapore
SINGAPORE (Sept 25): Raffles Medical Group last month signed an MoU with China Taiping Insurance Group (CTIG) to jointly provide medical insurance solutions as well as healthcare management services and explore health-linked property opportunities.
September 25, 2018
Broker's Calls
Raffles Medical eyes expansion on insurance front as medical tourism prospects stay weak
SINGAPORE (Aug 7): Raffles Medical Group recently obtained regulatory approvals to enter into the Integrated Shield market, officially launching Raffles Shield, on Aug 1.
August 07, 2018
Results
Raffles Medical 2Q earnings kept steady at $16.9 mil; health insurance products to be another growth factor
SINGAPORE (Aug 6): Raffles Medical Group's expansion into mass market health insurance products will be another growth factor for the group, says executive chairman Dr Loo Choon Yong.
August 06, 2018
Singapore-listed healthcare stocks up 9.2% YTD as they gun for growth
SINGAPORE (May 23): Stocks of the 15 largest Singapore-listed healthcare equipment and services companies with market caps above $100 million, have gained an average 9.2% year to date, according to data from the Singapore Exchange.
May 23, 2018
Broker's Calls
Launch of Raffles Medical's China hospitals a step closer to reality
SINGAPORE (May 3): OCBC is reiterating its “buy” recommendation on Raffles Medical with a fair value estimate of $1.26.
May 03, 2018
Results
Raffles Medical posts 1.7% rise in 1Q earnings to $15.8 mil
SINGAPORE (Apr 30): Raffles Medical Group posts a 1.7% increase in earnings to $15.8 million for the 1Q ended March, from $15.5 million a year ago.
April 30, 2018
Broker's Calls
Insurance co-pay seen to have little near-term impact on Raffles Medical
SINGAPORE (Mar 13): UOB KayHian is maintaining Raffles Medical Group at "buy" given it sees limited impact on the stock from changes in insurance co-pay terms for new policies.
March 13, 2018
Broker's Calls
This healthcare stock's FY18 growth potential is keeping analysts upbeat
SINGAPORE (Feb 27): OCBC Investment Research, Phillip Capital and UOB Kay Hian are maintaining their “buy” calls on Raffles Medical Group with a fair value estimate and target prices of $1.26, $1.32 and $1.32 respectively.
February 27, 2018
Results
Raffles Medical reports 0.8% rise in FY17 earnings to $70.8 mil
SINGAPORE (Feb 26): Raffles Medical Group reported a 0.8% rise in FY17 earnings to $70.8 million from $70.2 million a year ago.
February 26, 2018